Neuraptive Therapeutics, Inc. Strengthens its Board of Directors With Appointment of Cary Sucoff, J.D.
27 Feb 2023
Executive Change
PHILADELPHIA--(BUSINESS WIRE)-- Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries, announces the appointment of Cary Sucoff, J.D. to the company’s Board of Directors.
“On behalf of the Neuraptive Board and its directors, we are excited to welcome Cary to the board,” said Robert Radie, chairman, and chief executive officer of Neuraptive. “Cary’s extensive background in the capital markets, corporate strategy, legal, and compliance make him an important addition to the Neuraptive board of directors. We are excited to have attracted such an accomplished leader in our industry as we advance our lead program toward registration and commercialization
“I am excited to join the Neuraptive Board at this time in the company’s progression , and I look forward to working with the other directors on the board and the management team,” said Cary Sucoff
Mr. Sucoff has over 35 years of legal and securities industry experience, and since 2011, he has owned and operated Equity Source Partners LLC, an advisory and consulting firm. He is an expert in legal, compliance, corporate strategy, and capital markets and has participated in the financing of hundreds of public and private companies. Mr. Sucoff is a former New York City prosecutor and currently serves on the boards of directors of ContraFect Corporation, IMAC Holdings, LLC, Curative Biotechnology, Galimedix Therapeutics, Inc., and First Wave Technologies, Inc. Mr. Sucoff earned his J.D. from New England School of Law and his B.A. from SUNY Binghamton. Mr. Sucoff has been a member of the Bar of the State of New York (now retired) since 1978.
About Neuraptive
Neuraptive Therapeutics, Inc. is a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerve injuries. The company is headquartered in Chesterbrook, PA. For more information, see .
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.